IT1184889B - Procedimento per indurre una risposta immunitaria mediante immunizzazione con cellule incapsulate producenti antigeni - Google Patents

Procedimento per indurre una risposta immunitaria mediante immunizzazione con cellule incapsulate producenti antigeni

Info

Publication number
IT1184889B
IT1184889B IT67180/85A IT6718085A IT1184889B IT 1184889 B IT1184889 B IT 1184889B IT 67180/85 A IT67180/85 A IT 67180/85A IT 6718085 A IT6718085 A IT 6718085A IT 1184889 B IT1184889 B IT 1184889B
Authority
IT
Italy
Prior art keywords
immunization
inducing
procedure
immune response
cells producing
Prior art date
Application number
IT67180/85A
Other languages
English (en)
Other versions
IT8567180A1 (it
IT8567180A0 (it
Inventor
Allan P Jarvis Jr
Georg A Koch
Paul G Abrams
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of IT8567180A0 publication Critical patent/IT8567180A0/it
Publication of IT8567180A1 publication Critical patent/IT8567180A1/it
Application granted granted Critical
Publication of IT1184889B publication Critical patent/IT1184889B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT67180/85A 1984-05-24 1985-02-21 Procedimento per indurre una risposta immunitaria mediante immunizzazione con cellule incapsulate producenti antigeni IT1184889B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/613,803 US4680174A (en) 1984-05-24 1984-05-24 Induction of immune response by immunization with encapsulated antigen-producing cells

Publications (3)

Publication Number Publication Date
IT8567180A0 IT8567180A0 (it) 1985-02-21
IT8567180A1 IT8567180A1 (it) 1986-08-21
IT1184889B true IT1184889B (it) 1987-10-28

Family

ID=24458737

Family Applications (1)

Application Number Title Priority Date Filing Date
IT67180/85A IT1184889B (it) 1984-05-24 1985-02-21 Procedimento per indurre una risposta immunitaria mediante immunizzazione con cellule incapsulate producenti antigeni

Country Status (12)

Country Link
US (1) US4680174A (it)
JP (1) JPS60248627A (it)
AU (1) AU3450584A (it)
BE (1) BE902458A (it)
DE (1) DE3509202A1 (it)
DK (1) DK57785A (it)
FR (1) FR2564856A1 (it)
GB (1) GB2159172A (it)
IL (1) IL73246A0 (it)
IT (1) IT1184889B (it)
NL (1) NL8403352A (it)
SE (1) SE8404962L (it)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
EP0222360A3 (en) * 1985-11-12 1989-03-15 Biotherapeutics Inc. A method of producing a patient-specific cytotoxic reagent and composition
US6048729A (en) 1987-05-01 2000-04-11 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
JPH0687974B2 (ja) * 1990-03-27 1994-11-09 忠一 平山 発熱物質の吸着材料
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6054288A (en) * 1991-11-05 2000-04-25 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
US6692737B1 (en) 1991-11-05 2004-02-17 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
US6063630A (en) 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
WO1993017662A1 (en) * 1992-03-02 1993-09-16 Daratech Pty. Ltd. Improved implants
WO1993024076A1 (en) * 1992-05-29 1993-12-09 The Regents Of The University Of California Coated transplant and method for making same
US6531124B1 (en) 1992-07-10 2003-03-11 Transkaryotic Therapies, Inc. In vivo production and delivery of insulinotropin for gene therapy
US6670178B1 (en) 1992-07-10 2003-12-30 Transkaryotic Therapies, Inc. In Vivo production and delivery of insulinotropin for gene therapy
US7425543B2 (en) * 1992-11-16 2008-09-16 The Corporation Of Mercer University Microencapsulated materials and method of making same
EP0646000A4 (en) 1992-11-16 1997-05-02 Univ Mercer COMPOSITIONS CONTAINING MICRO-ENCODED NEUTRALIZING ANTIBODIES.
US5651980A (en) * 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
PL185338B1 (pl) * 1995-06-27 2003-04-30 Bavarian Nordic As Kapsułka otaczająca linię komórek pakujących produkujących cząsteczki retrowirusa, sposób otrzymywania kapsułki otaczającej linię komórek pakujących produkujących cząsteczki retrowirusa, zastosowanie kapsułki otaczającej linię komórek pakujących produkujących cząsteczki retrowirusa, sposób wytwarzania kompozycji farmaceutycznej oraz kompozycja farmaceutyczna
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
US6224912B1 (en) * 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
AU8577498A (en) * 1997-07-22 1999-02-16 General Hospital Corporation, The Modulation of multicellular aggregates by solid stress
JP2004527450A (ja) 2000-04-06 2004-09-09 シーア ファーマスーティカルズ エルエルシー 微生物送達システム
AU2003221579A1 (en) * 2002-04-30 2003-11-17 Canadian Blood Services Encapsulated cells to elicit immune response
EP1374893A1 (en) 2002-06-17 2004-01-02 NovImmune S.A. Vaccination with immuno-isolated cells producing an immunomodulator
US20040016013A1 (en) * 2002-07-18 2004-01-22 Gonzalo Hortelano Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent
US20040014698A1 (en) * 2002-07-18 2004-01-22 Gonzalo Hortelano Oral administration of therapeutic agent coupled to transporting agent
US20040014704A1 (en) * 2002-07-18 2004-01-22 Gonzalo Hortelano Oral administration of therapeutic agent coupled to transporting agent induces tolerance
US20050208032A1 (en) * 2004-01-16 2005-09-22 Gonzalo Hortelano Oral administration of therapeutic agent coupled to transporting agent
WO2006020891A2 (en) * 2004-08-13 2006-02-23 Anormed Inc. Chemokine combinations to mobilize progenitor/stem cells
AU2008289461A1 (en) 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
EP2205249B1 (en) 2007-09-28 2018-11-07 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
US10004790B2 (en) 2008-09-29 2018-06-26 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US10463608B2 (en) 2008-09-29 2019-11-05 The Corporation Of Mercer University Microneedle-based transdermal delivery system and method of making same
WO2010037142A1 (en) * 2008-09-29 2010-04-01 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US11524058B2 (en) 2008-09-29 2022-12-13 The Corporation Of Mercer University Oral dissolving films containing microencapsulated vaccines and methods of making same
ES2893750T3 (es) 2015-09-25 2022-02-10 Maxivax Sa Vacuna que comprende células inmunoaisladas que producen un inmunomodulador
US11628208B2 (en) 2015-10-05 2023-04-18 The Corporation Of Mercer University System and method for microneedle delivery of microencapsulated vaccine and bioactive proteins
WO2017062463A1 (en) 2015-10-05 2017-04-13 The Corporation Of Mercer University Nanospheres encapsulating bioactive material and method for formulation of nanospheres
US20240041755A1 (en) * 2020-12-22 2024-02-08 William Marsh Rice University Implantable constructs for modulating an immune response

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
SE8405105L (sv) * 1984-05-24 1985-11-25 Damon Biotech Inc Sett for screening av celler

Also Published As

Publication number Publication date
US4680174A (en) 1987-07-14
IL73246A0 (en) 1985-01-31
GB2159172A (en) 1985-11-27
DE3509202A1 (de) 1986-04-24
AU3450584A (en) 1985-11-28
NL8403352A (nl) 1985-12-16
SE8404962D0 (sv) 1984-10-04
IT8567180A1 (it) 1986-08-21
FR2564856A1 (fr) 1985-11-29
BE902458A (fr) 1985-09-16
DK57785D0 (da) 1985-02-07
GB8428321D0 (en) 1984-12-19
IT8567180A0 (it) 1985-02-21
JPS60248627A (ja) 1985-12-09
DK57785A (da) 1985-11-25
SE8404962L (sv) 1985-11-25

Similar Documents

Publication Publication Date Title
IT1184889B (it) Procedimento per indurre una risposta immunitaria mediante immunizzazione con cellule incapsulate producenti antigeni
DK323486D0 (da) Monoklont antistof mod et med human carcinom associeret antigen
IT1161239B (it) Procedimento per la preparazione di metilacetato
IT1160468B (it) Procedimento per la produzione di anticorpi monoclonali umani
DK138786A (da) Monoklont antistof rettet mod humant gangliosid gd2
IT7969049A0 (it) Dispositivo e procedimento per la foggiatura di lastre di vetro
KR850004442A (ko) 수소화 규소의 제조방법
IT1152200B (it) Microcapsule di etilcellulosa e procedimento per prepararle
IT8119620A0 (it) Procedimento per la preparazione di esteri della insulina.
NO863745D0 (no) Seismiske undersoekelser av lag.
IT8167059A0 (it) Procedimento per l ottenimento di una pretensione termica in vetri
DE3374246D1 (de) Fuel spacer
DK429284A (da) Reaktionsbeholder for immunologiske undersoegelser
DK283588A (da) Monoklonalt antistof mod ovariecancerceller
DE3587714D1 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DK144485A (da) Monoklonale antistoffer
IT1211385B (it) Metodo per la fabbricazione di strati monocristallini di tellururo di cadmio e mercurio
DK250085A (da) Vektorer til antigenekspression
IT8121940A0 (it) Preparazione fermentativa di l-isoleucina.
IT8322601A0 (it) Metodo per la preparazione diprodotti di combustibili nucleari.
GB2144129B (en) Antigens as immunostimulant adjuvants
JPS5719902A (en) Method of producing ceramic semiconductor element
DK240286A (da) Monoklonale antistoffer
IT1149090B (it) Antisiero antitumorale monospecifico e procedimento di preparazione
ES545168A0 (es) Vacuna contra la brucelosis